癌症的标志 :相关途径中的性变态性
Setareh Satari1,2,3, Inês N R Mota1,4, Ana Carolina Leão Silva1,2
1Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Pathology and Laboratory Medicine Dep./Clinical Pathology, Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.
International journal of molecular sciences
|May 14, 2025
概括
与癌症相关的缓解症 (CAC) 提出了复杂的挑战,明显的基于性别的差异影响了治疗. 了解这种性二态是开发消耗综合征个性化治疗的关键.
科学领域:
- 在瘤学瘤学.
- 代谢过程中的代谢.
- 生理学 生理学 生理学
背景情况:
- 癌症相关的 (CAC) 或消耗综合征是一种复杂的系统性疾病,通过各种代谢途径影响多个器官.
- 标志性特征包括炎症,减肥,脂肪组织枯竭和骨肌肉损伤.
- 目前的临床挑战包括由于CAC的复杂性,晚期诊断和缺乏标准化治疗.
研究的目的:
- 审查与癌症相关的缓解症相关的标志性途径中的性二态.
- 要突出生理性差异如何影响CAC呈现和进展.
- 倡导将女性纳入以性别为基础的治疗开发的缓解症研究.
主要方法:
- 文献综述,重点关注癌症相关缓解症的代谢途径和生理性性别差异.
- 分析现有关于缓解症机制和临床表现的研究.
- 综合有关炎症,新陈代谢和组织损耗中的性二态信息.
主要成果:
- 在涉及癌症相关缓解症的代谢途径中存在显著的性二态.
- 性别的生理差异导致男性和女性对缓冲症的反应有所不同.
- 目前的研究和临床研究往往低于女性,可能会扭曲理解和治疗.
结论:
- 了解CAC通路中的性二态是推动研究发展的关键.
- 优先考虑将女性纳入缓解症研究对于开发个性化,基于性别的疗法至关重要.
- 解决基于性别的差异可以提高治疗效率,并改善消耗综合征患者的治疗结果.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Notch Signaling Pathway
4.1K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.1K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K


